Screener
Neuropace, Inc. NPCE Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
| (in thousands, except for share and per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense), net | (41) | (486) | (206) | (568) |
| Net loss and comprehensive loss from continuing operations | (6,200) | (10,016) | (12,926) | (18,218) |
| Net income from discontinued operations | — | 1,365 | 37 | 2,978 |
| Net loss and comprehensive loss | $(6,200) | $(8,651) | $(12,889) | $(15,240) |
| Net loss per share from continuing operations attributable to common stockholders, basic and diluted | $(0.18) | $(0.30) | $(0.38) | $(0.57) |
| Net income per share from discontinued operations attributable to common stockholders, basic and diluted | $0.00 | $0.04 | $0.00 | $0.10 |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.18) | $(0.26) | $(0.38) | $(0.47) |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | 34,104,430 | 32,863,031 | 33,911,692 | 32,175,789 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Neuropace, Inc.'s shares (diluted)?
- Neuropace, Inc. (NPCE) reported shares (diluted) of 34.1M in Q2 2026.
- How has Neuropace, Inc.'s shares (diluted) changed year-over-year?
- Neuropace, Inc.'s shares (diluted) increased by 3.8% year-over-year, from 32.9M to 34.1M.
- What is the long-term trend for Neuropace, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s shares (diluted) has grown at a 22.1% compound annual growth rate (CAGR), from 58.5M to 130.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Neuropace, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude